Epstein Secrets

t and XDx, while maintaining board observer status with Labcyte. Vijay was previously on the boards of Advanced Cell Diagnostics, Ilypsa (acquired by Amgen) and Relypsa (NASDAQ: RLYP). Prior to joining Sprout, Vijay spent one year as an analyst in the healthcare venture capital group at Robertson Stephen

quently split to become 2 separate companies), Durata Therapeutics (NLV-II: IPO - July, 2012, NASDAQ: DRTX), and Ilypsa (Sprout IX, exited in sale to Amgen, 6.9x multiple). e Established Private Companies: The New Leaf Team has played the role of lead investor in a large number of private investments. T

of directors of Interlace (NLV-I company acquired by Hologic), Epicor (acquired by St. Jude), Visiogen (acquired by Abbott), PercuSurge (acquired by Medtronic), and NxStage Medical (NASDAQ: NXTM). Prior to joining the healthcare investment team at Sprout, Jeani was a General Partner at Weiss, Peck & Greer V

ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human

se Ship Ban Extension. • CDC Report On Meatpacking Plant Safety Procedures Was Revised To Soften Language. • DOJ Opens Antitrust Investigation Into Medtronic Over Ventilator Manufacturing. • As COVID Cases Rise, Insurers Reduce Coverage For Telehealth Visits. • Mnuchin, Pelosi To Continue Talks On Corona

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

ension. • CDC Report On Meatpacking Plant Safety Procedures Was Revised To Soften Language. EFTA00135714 • DO) Opens Antitrust Investigation Into Medtronic Over Ventilator Manufacturing. • As COVID Cases Rise, Insurers Reduce Coverage For Telehealth Visits. • Mnuchin, Pelosi To Continue Talks On Corona

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

se Ship Ban Extension. • CDC Report On Meatpacking Plant Safety Procedures Was Revised To Soften Language. • DO) Opens Antitrust Investigation Into Medtronic Over Ventilator Manufacturing. • As COVID Cases Rise, Insurers Reduce Coverage For Telehealth Visits. • Mnuchin, Pelosi To Continue Talks On Corona

ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

se Ship Ban Extension. • CDC Report On Meatpacking Plant Safety Procedures Was Revised To Soften Language. • DO) Opens Antitrust Investigation Into Medtronic Over Ventilator Manufacturing. • As COVID Cases Rise, Insurers Reduce Coverage For Telehealth Visits. • Mnuchin, Pelosi To Continue Talks On Corona